Significant Decrease of Cyclosporine Bioavailability in Rats Caused by a Decoction of the Roots of Scutellaria baicalensis

Abstract

Scutellariae Radix (SR), the root of Scutellaria baicalensis (Labiatae), is widely used in clinical Chinese medicine. In order to investigate the effect of SR on the absorption and disposition of cyclosporine, rats were administered with cyclosporine orally (in the form of the microemulsion Neoral®) and intravenously with and without coadministration of SR decoction in randomized cross-over designs, respectively. Furthermore, the effects of the major constituents, e. g., baicalin and its aglycone baicalein on cyclosporine pharmacokinetics were also investigated in rats. A specific monoclonal fluorescence polarization immunoassay was used to determine the blood concentration of cyclosporine. Our results indicated that coadministration of SR decoction at doses of 1 g/kg and 2 g/kg significantly decreased the C_max of cyclosporine by 62.9 % and 79.6 % and reduced the AUC_{0 - 540} by 55.2 % and 82.0 %, respectively. On the contrary, coadministration of baicalin and baicalein at doses of 112 μmol/kg markedly elevated the C_max of cyclosporine by 408.1 % and 87.5 % and increased the AUC_{0 - 540} by 685.3 % and 150.2 %, respectively. Nevertheless, SR decoction did not alter the pharmacokinetics of intravenous cyclosporine. These results indicate that a profound interaction between SR decoction and cyclosporine occurred at the absorption site. In order to ensure the efficacy and safety of cyclosporine, the coadministration of SR and its preparations with oral cyclosporine should be avoided.

Key words

Scutellaria baicalensis - Labiatae - cyclosporine - interaction - baicalin - baicalein

References

• 1 Fugh-Berman A. Herb-drug interactions.  Lancet. 2000;  355 134-8
• 2 Nijveldt R J, van Nood E, van Hoorn D EC, Boelens P G, van Norren K, van Leeuween P AM. Flavonoids: a review of probable mechanisms of action and potential applications.  Am J Clin Nutr. 2001;  4 418-25
• 3 Hodaek P, Trefil P, Stiborova M. Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450.  Chemico-Biol Inter. 2002;  139 1-21
• 4 Conseil G, Baubichon-Cortay H, Dayan G, Jault J M, Barron D, Di Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.  Proc Natl Acad Sci USA. 1998;  95 9831-6
• 5 Bosch I, Croop J. P-glycoprotein multidrug resistance and cancer.  Biochim Biophys Acta. 1996;  1288 F37-54
• 6 Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.  Proc Natl Acad Sci USA. 1987;  84 7735-8
• 7 Fromm M F. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.  Int J Clin Pharm Ther. 2000;  38 69-74
• 8 Chang H M, But P PH. Pharmacology and Applications of Chinese Materia Medica. Vol. 2 Singapore; World Scientific Publishing Co 1987: pp 1022-7
• 9 Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim S R, Monna T, Kobayashi K, Tango T. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9).  Cancer. 1995;  76 743-9
• 10 Small E J, Frohlich M W, Bok R, Shinohara K, Grossfeld G, Rozenblat Z. et al . Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.  J Clin Oncol. 2000;  18 3595-603
• 11 Kolars J C, Awni W M, Merion R M, Watkind P B. First-pass metabolism of cyclosporin by the gut.  Lancet. 1991;  338 1488-90
• 12 Lown K S, Mayo R R, Leichtman A B, Hsiao H L, Turgeon D K, Schmiedlin-Ren P. et al . Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine.  Clin Pharmacol Ther. 1997;  62 48-60
• 13 Edwards D J, Fitzsimmons M E, Schuetz E G, Yasuda K, Ducharme M P, Warbasse L H. et al . 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.  Clin Pharmacol Ther. 1999;  65 37-44
• 14 Lai M Y, Chen C C, Hsiu S L, Chao P DL. Analysis and comparison of baicalin, baicalein and wogonin contents in traditional decoctions and commercial extracts of Scutellariae Radix.  J Food Drug Anal. 2001;  9 145-9
• 15 Bailey D G, Arnold J MO, Munoz C, Spence J D. Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin.  Clin Pharmacol Ther. 1993;  53 637-42
• 16 Miniscalco A, Landahl J, Regardh C G, Edgar B, Eriksson U G. Inhibition of dihydropyridine in rat and human liver microsomes by flavonoids found in grapefruit juice.  J Pharmacol Exp Ther. 1992;  261 1195-9
• 17 Lai M Y, Hsiu S L, Tsai S Y, Hou Y C, Chao P DL. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.  J Pharm Pharmacol. 2003;  55 199-209
• 18 Lai M Y, Hou Y C, Hsiu S L, Chen C C, Chao P DL. Relative flavone bioavailability of Scutellariae Radix between traditional decoction and commercial powder preparation in humans.  J Food Drug Anal. 2002;  10 75-80
• 19 Yang C Y, Wang Y H, Hou Y C, Hsiu S L, Chao P DL. St. John’s Wort-cyclosporin interaction in rats and pigs.  Mid Taiwan J Med.. 2003;  8 127-33